Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Saved in:
| Title: | Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis. |
|---|---|
| Authors: | Springer JM; J.M. Springer, Associate Professor, MD, MS, Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Funk RS; R.S. Funk, Associate Professor, PharmD, PhD, Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas, USA. ryanfunk@kumc.edu. |
| Source: | The Journal of rheumatology [J Rheumatol] 2021 Nov; Vol. 48 (11), pp. 1718-1724. Date of Electronic Publication: 2021 Aug 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
